News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,279 Results
Type
Article (13626)
Company Profile (109)
Press Release (248544)
Section
Business (88000)
Career Advice (464)
Deals (15352)
Drug Delivery (64)
Drug Development (36550)
Employer Resources (49)
FDA (6263)
Job Trends (6190)
News (150129)
Policy (14016)
Tag
Academia (435)
Alliances (23143)
Alzheimer's disease (362)
Approvals (6273)
Artificial intelligence (66)
Bankruptcy (143)
Best Places to Work (4351)
Biotechnology (44)
Breast cancer (61)
Cancer (405)
Career advice (406)
Cell therapy (56)
Clinical research (30561)
Collaboration (194)
Compensation (80)
COVID-19 (748)
C-suite (58)
Data (427)
Diabetes (63)
Diagnostics (1246)
Drug pricing (59)
Earnings (31598)
Employer resources (43)
Events (36928)
Executive appointments (217)
FDA (6497)
Funding (130)
Gene therapy (62)
GLP-1 (304)
Government (1270)
Healthcare (3534)
Infectious disease (768)
Inflammatory bowel disease (49)
Interviews (58)
IPO (5853)
Job creations (2050)
Job search strategy (372)
Layoffs (168)
Legal (3414)
Lung cancer (55)
Manufacturing (110)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9570)
Metabolic disorders (194)
Neuroscience (472)
NextGen Class of 2024 (1581)
Non-profit (592)
Northern California (495)
Obesity (114)
Opinion (111)
Patents (64)
People (28572)
Pharmaceutical (67)
Phase I (7952)
Phase II (12927)
Phase III (11610)
Pipeline (197)
Policy (46)
Postmarket research (1400)
Preclinical (3180)
Radiopharmaceuticals (117)
Rare diseases (108)
Real estate (2630)
Regulatory (9891)
Research institute (563)
Resumes & cover letters (55)
Southern California (490)
Startups (1625)
United States (4863)
Vaccines (114)
Weight loss (83)
Date
Today (51)
Last 7 days (225)
Last 30 days (817)
Last 365 days (12518)
2024 (12471)
2023 (14255)
2022 (19582)
2021 (20122)
2020 (19074)
2019 (14901)
2018 (11714)
2017 (13889)
2016 (13130)
2015 (15475)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (43)
Asia (19872)
Australia (2571)
California (1161)
Canada (675)
China (138)
Colorado (46)
Connecticut (48)
Europe (38912)
Florida (183)
Illinois (135)
Indiana (96)
Japan (51)
Kansas (52)
Maryland (172)
Massachusetts (990)
Minnesota (64)
New Jersey (497)
New York (325)
North Carolina (293)
Northern California (495)
Pennsylvania (314)
South America (499)
Southern California (490)
Texas (161)
Virginia (46)
Washington State (79)
262,279 Results for "progenics pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”)(Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has entered into a definitive agreement with ProGen Co., Ltd.
June 24, 2024
·
7 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Business
Progenity and Ionis Pharmaceuticals Enter into Agreement to Evaluate Progenity’s Ingestible Oral Biotherapeutics Technology for Delivery of Antisense Therapies
Progenity , Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing products, today announced an agreement with Ionis Pharmaceuticals, the leader in RNA-targeted therapeutics, to evaluate the safety, tolerability and performance of Progenity’s Oral Biotherapeutics Delivery System (OBDS) for oral systemic delivery of antisense oligonucleotides
April 6, 2021
·
4 min read
Press Releases
Olympia Pharmaceuticals Announces the Launch of Sister Brand, Wesley Pharmaceuticals, in Honor of Beloved Employee
December 18, 2024
·
3 min read
Biotech Beach
Progenity to Become Biora Therapeutics as it Completes Transformation
Progenity, Inc. announced that it will change its name to Biora Therapeutics, Inc. during the second quarter of 2022, to better reflect the company’s focus on developing its pipeline for targeted and systemic oral delivery of biotherapeutics.
April 12, 2022
·
1 min read
Press Releases
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
November 27, 2024
·
1 min read
Biotech Beach
Progenity Announces Successful Transfer of Liquid Biopsy Technologies
Progenity, Inc. announced it has completed the divesture of a collection of novel, discovery-stage biochemical and bioinformatics technologies, including single-molecule detection, which are designed to enable next-generation rapid, low-cost assessment of biomolecules via liquid biopsy.
May 5, 2022
·
5 min read
Biotech Beach
Progenity Announces Two Poster Presentations at Controlled Release Society 2022
Progenity, Inc. today announced the acceptance of two abstracts presenting preclinical data on its systemic therapeutics delivery system for presentation at the Controlled Release Society (CRS) 2022 Annual Meeting.
April 6, 2022
·
1 min read
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
Deals
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Deciphera Pharmaceuticals, Inc. today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd.
April 29, 2024
·
10 min read
1 of 26,228
Next